Clinical Trials Logo

Clinical Trial Summary

Various morphological abnormalities of human oocytes were reported to detrimentally affect embryo development. We observed development of frozen thawed embryos derived from oocytes with normal or abnormal morphological features to the blastocyst stage. Cytoplasmic abnormalities of the oocytes were found to negatively affect cryosurvival potential of the embryos.


Clinical Trial Description

n/a


Study Design

Observational Model: Defined Population, Time Perspective: Longitudinal


Related Conditions & MeSH terms


NCT number NCT00521443
Study type Observational
Source V.K.V. American Hospital, Istanbul
Contact
Status Completed
Phase N/A

See also
  Status Clinical Trial Phase
Completed NCT02032797 - Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone. Phase 4
Recruiting NCT03913208 - Priority to Cryopreservation Strategy (PCS) in IVF-ICSI Cycles N/A
Completed NCT04011813 - Hypotaurine Supplementation Benefits in Cryopreservation
Recruiting NCT06261658 - Improving the Quality of Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma N/A
Completed NCT04487639 - Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male Oncological Patients ? N/A
Completed NCT06448000 - Effect of Long-time Human Sperm Storage in Liquid Nitrogen on Semen Parameters
Withdrawn NCT02687880 - Testicular Tissue Cryopreservation for Fertility Preservation in Male Patients Facing Infertility-causing Diseases or Treatment Regimens
Completed NCT03153436 - The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation Phase 1/Phase 2